Cognitive behavioral therapy (brief vs standard duration) for schizophrenia.

Area of Science:

• Psychiatry
• Clinical Psychology
• Mental Health Research

Background:

• Cognitive behavioral therapy for psychosis (CBTp) shows potential benefits for schizophrenia when combined with medication.
• Resource and training limitations hinder widespread CBTp provision.
• Brief forms of CBTp may offer a viable alternative in resource-limited settings.

Purpose of the Study:

• To review the effects of brief CBTp compared to standard CBTp in adults with schizophrenia.
• To identify existing randomized controlled trials (RCTs) comparing different durations of CBTp.

Main Methods:

• Searched the Cochrane Schizophrenia Group's Trials Register for relevant RCTs.
• Included studies involving adults diagnosed with schizophrenia or related disorders.
• Defined brief CBTp as therapy delivered within 4 months and 6-10 sessions.

Main Results:

• Identified only 7 studies utilizing a brief version of CBTp.
• No studies directly compared brief CBTp with standard-duration CBTp.
• Evidence for the efficacy of brief CBTp exists, but direct comparative data is lacking.

Conclusions:

• There is a significant need for RCTs directly comparing brief CBTp with standard CBTp.
• Standardized criteria for CBTp dosage (duration and session number) are required.
• Brief CBTp warrants further investigation as a potentially effective intervention for schizophrenia.